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Abstract  
Background: After hospital discharge, community pharmacists are often the first health care professionals the discharged patient 
encounters. They reconcile and dispense prescribed medicines and provide pharmaceutical care. Compared to the roles of general 
practitioners, the pharmacists’ needs to perform these tasks are not well known.  
Objective: This study aims to a) Identify community pharmacists’ current problems and roles at hospital discharge, b) Assess their 
information needs, specifically the availability and usefulness of information, and c) Gain insight into pharmacists’ objectives and ideas 
for discharge optimisation. 
Methods: A focus group was conducted with a sample of six community pharmacists from different Swiss regions. Based on these 
qualitative results, a nationwide online-questionnaire was sent to 1348 Swiss pharmacies. 
Results: The focus group participants were concerned about their extensive workload with discharge prescriptions and about gaps in 
therapy. They emphasised the importance of more extensive information transfer. This applied especially to medication changes, 
unclear prescriptions, and information about a patient's care. Participants identified treatment continuity as a main objective when it 
comes to discharge optimisation. 
There were 194 questionnaires returned (response rate 14.4%). The majority of respondents reported to fulfil their role as defined by 
the Joint-FIP/WHO Guideline on Good Pharmacy Practice (rather) badly. They reported many unavailable but useful information items, 
like therapy changes, allergies, specifications for “off-label” medication use or contact information. Information should be delivered in 
a structured way, but no clear preference for one particular transfer method was found. Pharmacists requested this information in 
order to improve treatment continuity and patient safety, and to be able to provide better pharmaceutical care services.  
Conclusion: Surveyed Swiss community pharmacists rarely receive sufficient information along with discharge prescriptions, although 
it would be needed for medication reconciliation. According to the pharmacist’s opinions, appropriate pharmaceutical care is therefore 
impeded. 
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INTRODUCTION 
Hospital discharge is a critical step in patient care. A patient 
experiences a mean of four medication changes and may 
suffer from adverse drug events during their stay.1-3 The 
therapy at discharge has to be continued as prescribed by 
the clinicians until the next consultation with a general 
practitioner (GP). However studies from Australia and 
Switzerland show that GP appointments are often 
delayed.4,5 In some countries, community pharmacists are 
therefore the first health care professionals encountered 
by the recently discharged patient, providing medication 
supply and pharmaceutical care.2 
Insufficient communication between hospitals and 
community pharmacists was identified as a main barrier to 
appropriate medication reconciliation.6 It can lead to 
discrepancies between different documentation7,8, 
medication supply gaps9, and subsequent hospital 
readmissions .10 The readmission rate may be reduced by a 
community pharmacy-based intervention.11 Drug related 
problems were detected in 25% of hospital discharge 
prescriptions.12 In these cases, pharmacies had to handle 
prescriptions without quantities or with unusual doses. A 
recent intervention study in a Swiss region, aiming at 
optimising communication found a reduction of 
interventions by the community pharmacies after an in-
hospital intervention.4 But it is unknown if the performed 
optimisations met the pharmacists’ needs and objectives. 
To our knowledge, no study so far has compared the 
currently available information with the desired 
information in a mixed method study. 
The needs and wishes of subsequent health professionals 
when dealing with discharged patients have been studied 
for GPs, pointing out the insufficient quality and quantity of 
information transfer.
13-17
 One study in GPs compared the 
available and desired information after discharge and 
found significant discrepancies.18 Information about drug 
discontinuation was available for 14% of GPs, while 89% 
desired to receive it. The authors also compared 
information desire between GPs and community 
pharmacists and found very similar needs. Even though 
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pharmacists are often encountered earlier as many patients 
visit them before the GP, there are only a few studies 
focusing on them.18-23 These studies assessed the 
information transfer from hospitals, the community 
pharmacists’ challenges and needs in France, United 
Kingdom and Belgium. The survey with Belgian community 
pharmacists conducted after a prospective study found that 
they are highly interested in obtaining more information at 
discharge.19 
In Switzerland, GPs are automatically provided with the 
discharge summary, but its content depends on the 
hospital software and the prescriber.12,16 Patients usually 
receive summaries along with their discharge prescription, 
but it remains unclear how many of them hand it to their 
pharmacist. A specialty of the Swiss health care system is, 
that in some regions prescribed medicines may be 
dispensed directly by physicians, their medical team or 
hospitals (so called “self-dispensing”).24 Some hospitals 
provide bridging supplies to their discharged patients, 
whilst others have public pharmacies. Therefore, 
community pharmacies in Switzerland may play different 
roles depending on regions.  
According to the Joint-FIP/WHO Guidelines on Good 
Pharmacy Practice, pharmacists should fulfil certain roles, 
such as “provide effective medication therapy 
management” (Role 2).25 Specifically, Function B (“manage 
patient medication therapy“) outlines that pharmacists play 
an essential role in evidence based treatment. They take 
the responsibility for coordinating the interdisciplinary 
team’s work, and transfer their knowledge to other health 
care professionals in order to ensure appropriate 
medication use. Function C encourages community 
pharmacists to “monitor patient progress and outcomes“. 
By assessing, interpreting and documenting clinical data 
and test results, pharmacists may monitor and influence 
health outcomes of their patients. But, in order to fulfil 
these roles, access to therapy-related, health-related and 
care-related data and collaboration on an organisation-
related level are essential. To our knowledge, there is no 
study evaluating if pharmacists fulfil these roles. 
This study aims to a) Identify community pharmacists’ 
current problems at hospital discharge, their self-defined 
roles and the fulfilment of internationally defined roles, b) 
Assess the information needs by evaluating current 
availability and usefulness of information in community 
pharmacies, specifically therapy-, health-, care- and 
organisation-related information, and c) Gain insight into 
community pharmacists’ objectives and strategies for 
discharge optimisation. 
 
METHODS 
The mixed method approach comprised both qualitative 
and quantitative measures. The qualitative focus group 
discussion helped to gain a deeper insight in the subject in 
order to design the subsequent quantitative 
questionnaire.26  
This study did not involve health related patient 
information, nor health or illnesses were studied. 
Therefore, according to Swiss law on human research, no 
ethical approval was needed.27 
Focus group  
The focus group was conducted with a convenience sample 
of six community pharmacists. They were pragmatically 
chosen from the authors’ professional contacts to 
represent different subgroups in age, sex, regional health 
care system (e.g. self-dispensing model), experience and 
position within the pharmacy. The inclusion criterion was 
current employment in a Swiss community pharmacy. 
Pharmacists were initially contacted by phone. 
The focus group session, led by two investigators, followed 
a script with seven open-ended questions: 
1. “Please state the role of your pharmacy when your client 
is discharged from hospital.” 
2. “In your experience, what are the most frequent 
problems that you encounter at hospital discharge?” 
3. “Assume that the hospital staff (e.g. physician, 
pharmacist, nurse) provides information about the 
discharged patient, in addition to the standard 
prescription. Please state all information that would be 
useful or interesting for your daily work.”  
4. ”We collected useful and interesting information items 
and the study team added some ideas. Please vote 
with green and orange cards for useful and unuseful 
items, and vote with the yellow card for a neutral 
opinion.”  
5. “So far we collected information items that could be 
transferred to community pharmacies in future. 
Pharmacists need competencies to deal with such 
information. Which competencies do pharmacists have 
that should be used, and which competencies are not 
available but should be acquired?” 
6. “Assume that the selected information items could be 
transferred to the community pharmacy. How should 
they be transferred?” 
7. “We talked a lot about information transfer. Do you have 
other suggestions, how to facilitate care after 
discharge?" 
The discussion was videotaped, to have a clear 
identification of the speakers on the audio line. Data 
saturation was not addressed. After a verbatim 
transcription of the discussion, a content analysis was 
performed inductively using a framework approach.28 The 
transcript was fragmented and categorised by two 
investigators separately with MAXQDA (version 11.0.1, 
Foxit Software Company, Berlin).28 Different fragmentation 
and categorisation of the data were discussed between 
researchers until consensus was reached. Statements 
within a category are summarised in the results section to 
provide the frequency of different topics discussed. They 
are presented in parentheses. 
Questionnaire  
The questionnaire was developed by all authors according 
to the aims and inspired by findings of the focus group. 
Structure, question types and wording were discussed 
extensively. The final version included six subjects:  
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a)  Sociodemographic and pharmacy characteristics 
adapted to other Swiss surveys for comparability29-32;  
b)  Estimated numbers and origin of prescriptions (The 
categorisation of hospital types was adapted from the 
Federal Office of Public Health reporting style33);  
c)  Fulfilments of the fully presented Functions B and C of 
the Joint-FIP/WHO Guideline25, evaluated with a 5-point 
Likert-scale (very good, good, satisfactory, bad, very 
bad). For easier presentation in the results’ section, the 
5 points were symmetrically aggregated to 3 points;  
d)  28 items addressing information (derived from the focus 
group discussion), divided into four categories: therapy-
related (A), health-related (B), care-related (C), and 
organisation-related information items (D), 
supplemented by two items on collaboration on an 
organisational level (E). They were evaluated on their 
availability by a 3-point Likert-scale (always or almost 
always, sometimes, never or almost never available), 
and on their usefulness by a 4-point Likert-scale 
(essential, desirable, neutral, not desirable34);  
e)  Objectives for discharge optimisation derived from the 
focus group and presented in a single-choice question 
with respondents asked to choose one out of a possible 
five answers;  
f)  An empty text field for additional comments. 
The questionnaire was piloted by three focus group 
participants and two pharmacists with both research and 
practical hospital experience. After minor adjustments in 
wording and methodology, the questionnaire in German 
was translated forwards and backwards into French and 
Italian, the two most widespread of the four official Swiss 
languages after German. All translators were native 
speakers of the language they translated into, and resided 
within Switzerland, as proposed by Wild et al.35 They were 
hospital or clinical pharmacists with experience in 
community pharmacies. 
The questionnaire was formatted electronically (Flexiform 
2.7.0, University of Basel) and sent by email to all managers 
of pharmacies belonging to the Swiss Pharmacist’s 
Association (n=1348). A reminder was sent after 24 days 
and the survey was closed after 49 days. Data analysis was 
done with SPSS Statistics (IBM, version 22.0.0.0). 
 
RESULTS  
Thematically similar results from the focus group discussion 
and the questionnaire are presented, related to each other, 
in the results' subsections. Subsections refer to the three 
aims. Pharmacists contributing to the focus group are 
named „participants“, while pharmacists answering the 
questionnaire are called „respondents“. Characteristics of 
participants and respondents are shown in Table 1 and 
Table 2. Of 1348 questionnaires sent out, 194 (14.4%) were 
completed and returned.  
Current problems and roles  
The study aimed to identify the community pharmacists’ 
most important problems at hospital discharge. Focus 
group participants identified significant challenges within 
the current practice. Their workload and organisational 
barriers were addressed repeatedly (12 statements), which 
lead to waiting times for the discharged patients. 
“The hospital […] discharge is a huge problem, 
because it mostly happens during the weekends. 
And on weekends, the respective general 
practitioners are not available.” (P3) 
“We telephoned for hours, because the doctor on 
call wasn’t there anymore.” (P4) 
The change of medication or brands was judged as a major 
safety issue for patients (19 statements):  
Table 1. Characteristics of the six focus group participants. Mean age was 47.3 years (SD=13.7). 
Participants Sex 
Age  
[years] 
Experience in  
community [years] 
Position in 
pharmacy 
Dispensing by physicians in the 
pharmacist’s region 
Participant 1 Female 40 15 Employee No self-dispensing 
Participant 2 Male 65 38 Owner No self-dispensing 
Participant 3 Male 30 5 Employee No self-dispensing 
Participant 4 Female 40 15 Manager No self-dispensing 
Participant 5 Male 47 15 Owner Self-dispensing 
Participant 6 Female 62 26 Employee Self-dispensing 
Table 2. Characteristics of 194 questionnaire respondents and 
their pharmacies. 
Respondents n (%) 
Mean age; years [SD] 49.7 [10.8] 
Female gender 98 (50.5) 
Experience in community pharmacy  
< 2 years 2 (1.0) 
2 - 5 years 11 (5.7) 
5 - 10 years 16 (8.2) 
10 - 20 years 35 (18.0) 
> 20 years 130 (67.0) 
Pharmacies n (%) 
Location  
City centre 47 (24.2) 
Urban quartier 58 (29.9) 
Agglomeration 37 (19.1) 
Countryside 52 (26.8) 
Pharmacist full-time equivalent  
< 100% 10 (5.2) 
101 - 200% 111 (57.2) 
201 - 300% 54 (27.8) 
> 300% 19 (9.8) 
Median prescriptions per month [SD] (5 invalid) 800 [1127] 
Discharge prescriptions as percentage of all filled 
prescriptions 
 
0% 3 (1.5) 
10% 120 (61.9) 
25% 52 (26.8) 
> 50% 19 (9.8) 
Most frequent origin of discharge prescriptions  
Hospitals for centralised care (e.g. university 
hospitals) 
113 (58.2) 
Hospitals for basic care (e.g. regional 
hospitals) 
76 (39.2) 
Specialised clinics (e.g. rehabilitation, 
psychiatric clinics) 
5 (2.6) 
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“It has happened more than once that the same 
active ingredient is prescribed multiple times. The 
general practitioner prescribes, then you are 
admitted to the hospital, the discharge prescription 
comes back […].” (P2) 
Participants referred to the expectations of patients and 
other health care professionals. They experienced being 
assigned the role of a supplier only (2 statements): 
“[...] the expectation when you enter a pharmacy is 
that you have to get it [the medication] 
immediately. That’s the expectation of my clients.” 
(P5) 
Participants considered the collaboration with other health 
professionals as one of their competencies, and ensuring 
the treatment continuity was emphasised as an important 
task. Confronted with the complete Functions B and C out 
of Role 2 from the Joint-FIP/WHO-Guidelines, 56.7% and 
73.7% of questionnaire respondents respectively judged 
their ability to fulfil these roles as (rather) bad (Table 3). 
Table 3. Answers of questionnaire respondents about fulfilling Joint-FIP/WHO Guidelines on Good Pharmacy Practice. 
The five item Likert-scale was symmetrically aggregated to 3 items.  
 
(rather) good 
n (%) 
satisfactory 
n (%) 
(rather) bad 
n (%) 
Function B: Manage patient medication therapy 37 (19.1) 47 (24.2) 110 (56.7) 
Function C: Monitor patient progress and outcomes 20 (10.3) 31 (16.0) 143 (73.7) 
Table 4. Questionnaire results about availability (1
st
-3
rd
 column) and usefulness (4
th
-7
th
 column) of categories A-D addressing information 
and organisational collaboration (n=194). 
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A: Therapy-related information         
Complete patient identification, e.g. age 181 12 1 177 15 1 1 n.r. 
Complete, up to date medication list 56 117 21 154 39 1 - 5 
Therapy on admission 34 90 70 51 116 26 1 6 
Therapy changes in hospital 24 97 73 110 79 4 1 6 
Reasons for therapy changes 6 33 155 80 102 11 1 1 
Therapy duration 82 104 8 169 24 1 - 6 
Therapy goals 6 38 150 49 127 16 2 6 
Therapy indication 8 51 135 54 124 14 2 4 
Off-label use is marked 10 41 143 127 57 9 1 6 
Emergency limits, e.g. blood pressure 8 43 143 89 93 10 2 6 
Interventions performed in hospital 16 26 152 53 118 20 3 4 
Information about if supply was given to the 
patient (n=193) 
18 40 135 52 108 23 1 4 
B: Health-related information         
Reason for hospital admission 6 43 145 28 127 35 4 4 
Major and minor diagnoses 1 28 165 43 129 20 2 3 
Description of wounds and their treatment 1 42 151 56 117 20 1 6 
Allergies  7 72 115 143 48 3 - 6 
Laboratory values to control therapy - 20 174 26 108 51 9 6 
Laboratory values to control side effects  1 7 186 24 99 59 12 6 
Laboratory values of kidney and liver  1 8 185 27 85 69 13 6 
C: Care-related information         
Next health care provider appointment 3 82 108 45 124 23 2 4 
Further care organisation, e.g. nurse visits  4 68 122 35 140 16 3 6 
D: Organisation-related information         
Contact information of treating personnel 85 96 13 142 49 2 1 6 
Contact information of hospital pharmacy 
(n=193)  
46 59 88 40 105 46 3 n.r. 
Hospital’s formulary  10 48 136 22 117 53 2 n.r. 
Hospital pharmacy’s documents e.g. lists about 
Tablet crushing 
20 66 108 45 116 30 3 3 
Hospital’s compounding formulations  23 103 68 56 125 12 1 n.r. 
Hospital’s guidelines on diseases 4 39 151 35 125 32 2 n.r. 
Information about how to order special 
medicines  
20 62 112 40 113 41 - 4 
E: Organisational collaboration         
Hospitals give supply to patients at discharge 15 83 96 52 108 28 6 4 
Shared education with hospital personnel 6 12 176 9 116 58 11 3 
Results are supplemented with ratings with green cards in the focus group (n=6, last column). Some information was not proposed for 
rating and therefore not rated (n.r.) during focus group. The most frequent answers are presented in bold numbers. 
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Good or rather good fulfilment was declared by 19.1% and 
10.3% of respondents respectively. 
Information needs 
The 28 different information items from the questionnaire 
(A-D) are presented in Table 4. All items were rated as 
being less accessible than required, except for one 
respondent who reported exceptionally good access. 
Furthermore, participants from the focus group were highly 
interested in obtaining more information (rating of 
usefulness by green cards, Table 4).  
The category of therapy-related information (A) was 
considered the most useful by focus group participants (24 
statements), e.g. specifications of the prescription like 
therapy duration or “off-label” use and medication 
changes. 
“[...] we have a lot of work to reconstruct what 
changed in the hospital and what didn’t. It needs a 
lot of work.” (P1) 
Changes of brands were highlighted to be frequent. 
Participants mentioned that for consumers registered in 
their pharmacy, the medication history allows them to 
reconstruct changes. But, if the prescription contains only a 
selection of medication – those which have to be obtained 
at the pharmacy – and not the whole medication list, 
missing products might be interpreted as discontinued.  
“What troubles me is retracing what has been 
stopped [...]. So, was phenprocoumon stopped or 
was it forgotten on the prescription or is only 
acetylsalicylic acid the current treatment [...]. That is 
a big problem […]." (P1) 
All participants suggested that prescriptions should be 
specified with “stopped” or "new since”. The reasons for 
therapy changes were desired only by one participant, 
others indicating they would be unsure how to deal with 
such clinical details. They state lacking expertise in 
interpreting and validating the decisions of other health 
care professionals. Therefore, they thought the knowledge 
that there was a change would suffice. This is congruent 
with the answers to the questionnaire, where 110 (56.7%) 
respondents stated to be satisfied knowing that there was 
a change performed, and 80 (41.2%) respondents judged 
the reason for the change as essential information.  
Focus group participants complained about insufficient 
information on intended unusual dosages or “off-label” 
use. All six said that the provision of explicit specification 
like the Latin “sic” would be useful (10 suggestions). This 
would save pharmacists from “running after these things” 
(P1). 127 of 194 (65.4%) questionnaire respondents 
supported this statement about specifications for “off-
label” use. 
Concerning the category of health-related information (B), 
all participants stated that information about patients’ 
wound care would be helpful. Participants felt competent 
in wound management, but said that their knowledge 
could be extended. Opinions about the importance of other 
health-related information like diagnoses were 
controversial between the two groups. Laboratory values 
were desired by all participants, but only with a clear 
purpose, e.g. to detect side effects. They confirmed being 
familiar with common values like blood glucose levels, 
however, they felt incompetent in judging the clinical 
relevance of uncommon values and called for further 
training. Allergy information was rated as essential by all six 
participants. In the questionnaire, 79 (40.7%) respondents 
declared to have at least sometimes access to allergies, and 
191 (98.4%) desired access.  
Regarding care-related information (C), all six participants 
said it is important to know the follow-up procedure (10 
suggestions), for example, who is caring for the patient 
after discharge. This was supported by 175 of 194 (90.2%) 
questionnaire respondents, whilst only 19 (9.8%) had a 
neutral or opposing opinion. 
Objectives and strategies for discharge optimisation  
An urgent need for optimisation of the discharge process 
was claimed by all focus group participants, and different 
objectives were suggested. A reduction of workload was an 
objective often mentioned, with regard to their own work 
(12 statements, Table 5). But for patients, they saw 
treatment continuity as the major objective (22 
statements), with pharmacists feeling responsible for 
bridging patients’ medication supply gaps. In the 
questionnaire, respondents chose better pharmaceutical 
counselling and care to be targeted by any discharge 
optimisation, whereas the workload was not a priority in 
this single-choice question (Table 5).  
Different strategies to achieve the stated objectives were 
found. Besides the information content, its transfer and 
display were discussed in the focus group. Participants 
emphasised the need for new information technology like 
electronic patient records (17 statements), but were 
concerned about their confidentiality. Therefore, paper-
based solutions were requested (8 statements). The 
questionnaire respondents’ major preference was for 
electronic methods (52 of 194, 26.8%, Table 6), this was 
especially true for respondents with 5 - 10 years of 
experience. The less experienced the respondents were, 
the more likely they preferred the prescription. This and 
other paper-based solutions like summaries or medication 
charts were also highly rated as acceptable methods by the 
respondents (Table 6). The timing of information transfer 
was judged to be crucial. Participants suggested that 
prescriptions with additional information should be sent to 
Table 5. Objectives of pharmacists for potential discharge optimisations, stated in the focus group (n=6) and in the questionnaire 
(single choice question, n=194).  
 Statements in focus group; n (%) Answers in questionnaire; n (%) 
Improved continuity of supply 22 (32.4) 48 (24.7) 
Improved medical treatment (e.g. safety) 19 (27.9) 63 (32.5) 
Reduction of work load 12 (17.6) 1 (0.5) 
Improved counseling and pharmaceutical care  11 (16.2) 77 (39.7) 
Improved patient satisfaction  4 (5.9) 5 (2.6) 
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the pharmacy before discharging the patient (16 
statements). 
Concerning display, participants noted that it should be 
possible to write the information simply and briefly (6 
statements). Structured information was prioritised over 
free text by 154 questionnaire respondents (Table 6), which 
was similar to the focus group. 
“In the end, to be realistic, you have to bring it in a 
form that also saves time for the doctor.” (P3) 
Participants preferred to receive concise and clearly 
arranged information over long summaries, in order to find 
the essential into information quickly (10 statements).  
“I don’t want to download a whole patient record 
and then to pick out what is relevant for me.” (P4) 
Besides optimisation through an enhanced information 
transfer regarding patient therapy, health and care, 
participants expressed a need for general collaboration 
between hospitals and pharmacies. Questionnaire 
respondents stated a desire for the provision of 
organisation-related information (D, Table 4). Focus group 
participants repeatedly stated that they feel dependent on 
hospitals. They lack information about hospital's guidelines 
and formularies to adapt their stock (16 statements). 
Participants described further initiatives: 
“What I experienced more than once and what I 
greatly appreciated was: When [...] the doctor 
already knew that it was a special product or an 
uncommon medicine, he called before discharging 
the patient [...] and asked if we had it in stock.” (P3) 
Further suggestions for the provision of organisation-
related information were to get lists of medicines 
prescribed for “off-label” use, to get instructions on 
extemporaneously compounding formulations, and on 
where to order foreign medication. Pharmacists also called 
for contact information of the hospital pharmacy staff. Four 
participants stated they would appreciate if the hospitals 
provided supply to prevent therapy gaps, and it would be 
good to know if a patient already had received supply on 
discharge. They called for shared education to enhance 
collaboration on an organisational level (E, Table 4). 
When asked for other optimisation ideas in a text field of 
the questionnaire, respondents again mentioned already 
discussed subjects. These were namely the importance of 
knowing medication changes for the patient’s safety and 
the advantages of information being available early. No 
new ideas were raised.  
DISCUSSION 
This is the first published study evaluating current practices 
of information transfer between hospitals and community 
pharmacies in Switzerland, in direct comparison with the 
needs and objectives expressed by community pharmacists. 
To summarise, community pharmacists stated to have 
limited access to essential information, and they called for 
further therapy-related, health-related, care-related, and 
organisation-related information. A need for discharge 
optimisation and organisational collaboration was claimed 
by both the participants in focus group discussion and the 
community pharmacists responding to the questionnaire. 
Better counselling, treatment continuity for patients, and 
reduced workload for pharmacists were identified as major 
objectives.  
In particular, this study revealed that community 
pharmacists see the hospital discharge as an important 
step in care transition. Participants and respondents 
complained about a lack of information, which impairs 
patient care in daily practice. These challenges are as well 
described in the literature.20,36 Both groups reported 
treatment gaps to be a frequent consequence. To 
compensate, community pharmacists invest a lot of time 
and effort in avoiding therapy gaps and in fulfiling their role 
as therapy managers. However, questionnaire respondents 
who were confronted with the Joint-FIP/WHO Guideline on 
Good Pharmacy Practice stated that they do fulfil their role 
(rather) badly. Focus group participants felt capable of 
doing more than just dispensing medicine, and they wished 
to apply their expertise more often. A comparison of the 
provision of pharmaceutical care by community 
pharmacists across Europe revealed over-average scores 
for Switzerland e.g. in direct patient care activities and in 
patient monitoring.31 These conflicting findings may be due 
to methodology that limits the value of self-reported 
behaviour. It would be of interest to study how other 
European pharmacists judge their role fulfilment if 
confronted with the Joint-FIP/WHO Guideline. 
Nevertheless, our study indicates a high need for better 
exchange of information at discharge, and revealed the 
potential of community pharmacists to improve treatment 
continuity.  
Regarding content of the information, four categories (A-D) 
evolved from the focus group discussion (Table 4). The 
availability of the different items varied significantly, and it 
differed also among pharmacies. This is possibly due to 
special settings which combine a GP practice and a 
pharmacy; a new development in Switzerland. Outstanding 
examples of pharmacies with extended collaboration were 
Table 6. Preferred transfer methods and display of information (single-choice question, n=194 respondents). 
Medium n (%) 
as electronically accessible record 52 (26.8) 
as separate, special form 49 (25.3) 
on the discharge prescription 47 (24.2) 
on the medication chart 26 (13.4) 
on the discharge summary 18 (9.3) 
other (e.g. personal message) 2 (1.0) 
Design n (%) 
Addition of structured information (e.g. as checkboxes) 82 (42.3) 
Specification of existing information (e.g. 'sic', 'stop' for certain prescription lines) 72 (37.1) 
Addition of free text 36 (18.6) 
Others (e.g. pictograms, electronic patient record) 4 (2.0) 
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also described before22, but it is unknown if specialised 
pharmacies with a GP practice in the community pharmacy 
responded to the questionnaire. It needs to be taken into 
account that respondents may have answered for general 
availability of information, and not always specifically for 
recently discharged patients. However, all respondents 
deplored insufficient quantity and quality of information, as 
well as delayed information transfer. 
Looking at the categories (A-D) in detail reveals a mixed 
pattern. Therapy-related items (A) like patient 
identification, therapy duration or up-to-date medication 
lists were rated with the highest availability. In accordance 
with that, they are also valued the most essential by the 
respondents. During a hospital stay, therapy changes such 
as new or altered treatments are common.1 However, our 
results show that they are usually not communicated, 
which makes medication reconciliation labour-intensive. 
Therefore, detailed information on changes was strongly 
desired, as well as a complete list containing all medicines a 
patient should use. Other studies had similar findings, 
where pharmacists and GPs also stated a need for more 
information about medication changes.6,16 Surprisingly, 
information about reasons for changes was not as desired 
as the information that there was a change. This is 
congruent with a Belgian study.19 Pharmacists seem not to 
reevaluate clinical decisions, which may be due to a lack of 
time or limited clinical expertise. Regarding stop orders, 
focus group participants repeatedly stated that insufficient 
transfer of such information may put patients at risk. The 
explicit need for this information was supported by 
literature, where 76% of interviewed American pharmacists 
saw a need for this information.18 Likewise, this was put on 
a “wish list” by Kennelty et al.6 A second therapy-related 
focus was “off-label” use. It usually remains hidden 
because diagnoses are rarely accessible for community 
pharmacists. In this situation the indication would be 
essential in order to check the appropriateness of the 
prescription.  
Information items categorised as health-related (B) are 
almost never available. Within those items, allergies were 
accessible to some responding pharmacies. Allergy 
information was considered essential by most of the 
respondents, matching results of previous studies.18,19 
Interestingly, other health-related items like kidney 
function results were significantly less desired. This may be 
due to a lack of experience in judging the appropriateness 
of individual doses. This low interest in clinical details 
opposes earlier statements, that pharmacists would rather 
be seen as competent health care professionals. Although, 
focus group participants called for further education in 
these topics, for example evaluation of laboratory results 
and wound care. 
Besides dispensing and counselling a patient, pharmacists 
have a role in coordinating patient care.25 Therefore, care-
related information (C) would be helpful but is currently 
only sometimes available. The knowledge of a patient’s 
social situation, the needs for support in the management 
of medicines or the information about the next 
appointment with the GP would enable community 
pharmacists to fulfil their role more adequately. Our 
findings underline similar results from other studies, where 
the date of the next GP appointment or knowing how the 
patient manages their medication at home were highly 
rated.6,19 With this information, coordinating care within 
the interdisciplinary team would be easier for pharmacists.  
In both study parts, different objectives for discharge 
optimisation evolved. During focus group discussion, there 
was a desire for reducing the pharmacist's workload, whilst 
in the questionnaire, more patient-oriented than 
pharmacist-oriented objectives were chosen. This 
discrepancy may be due to methodological reasons (free 
discussion versus single-choice question). However, 
objectives expressed by participants and respondents were 
similar to a Belgian and a Swiss intervention study, where 
continuity of treatment was targeted.19,37 To achieve the 
above mentioned optimisations, different strategies were 
discussed. Participants and respondents suggested an 
enhanced information transfer from hospital to community 
pharmacy. No other substantial concepts were discussed 
when participants were asked for additional ideas, 
highlighting this as a priority issue.  
Pharmacists in both settings insisted on an early transfer of 
information. They preferred concise and clearly structured 
information. A well-designed form would help hospitals to 
implement such documentation, and pharmacists to read it 
efficiently. While questionnaire respondents prioritised 
electronic tools, focus group participants preferred paper-
based solutions like handovers, because they were afraid of 
any implementation delay with a new system. Surprisingly, 
there was no clear trend of younger pharmacists preferring 
electronic tools. However, electronic platforms were 
welcomed for organisation-related information (D). Such 
organisation-related information was sometimes or seldom 
accessible, although rated as very helpful. As a general 
impression from the focus group discussion, pharmacists 
see their surrounding hospitals as “lucky dips” or "black 
boxes”, not knowing what happens inside and being 
surprised by what comes out. Similar opinions have been 
collected among Swiss GPs.13 Personal knowledge of the 
treating personnel may enhance collaboration.6,19 Through 
extended collaboration on an organisational level (E), e.g. 
shared education, this impression of GPs and community 
pharmacists may be diminished.  
Some limitations have to be taken into account. This was a 
mixed method approach leading to qualitative, and 
subsequent quantitative results. Country- and population-
specific characteristics like self-dispensing may limit 
applicability to other health care systems. There may be a 
selection bias for pharmacists, however, age29,38, 
gender29,30,38 and experience31 of respondents, as well as 
location29,31 and size32,38 of pharmacies, were very similar in 
both groups compared to other studies. There was no 
evaluation of different pharmacy settings, which would 
have been useful to compare. Response to the 
questionnaire was rather low compared to response rates 
of 43 - 57.4% in similar settings.29-31,38 This may be due to 
an overload of surveys being sent to this population lately 
and the fact that the questionnaire was sent to pharmacies 
and not to personal email accounts. A response bias cannot 
be excluded. The mixed method approach helped to enrich 
the knowledge gained from the 194 respondents, enabling 
a broader insight in the subject. Through focusing on 
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information transfer, other important strategies of 
discharge optimisation may have gone underreported. 
 
CONCLUSIONS 
To conclude, insufficient communication at hospital 
discharge may cause therapy interruptions and introduce 
additional workload for community pharmacists. Although 
the very essential therapy-related information is 
sometimes available for Swiss community pharmacists, 
desired health-related and care-related information is 
mostly inaccessible. Interviewed community pharmacists 
called for enhanced collaboration to support patient safety, 
mainly through information transfer. Its layout was hoped 
to be concise and well-structured to enable quick and easy 
reading. No clear preference for a transfer method was 
identified. We recommend that any optimisation of 
hospital discharge should be adapted to community 
pharmacists’ competencies and needs. With this, they 
would possibly be more able to support patients in their 
therapy to their best. 
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